79 Results

People

  1. Zelenetz
    Zelenetz
  2. Schoder
    Schoder
  3. Noy
    Noy
  4. Hamlin
    Hamlin
  5. Matasar
    Matasar
  6. Horwitz
    Horwitz
  7. Kumar
    Kumar
  8. Moskowitz
    Moskowitz
  9. Palomba
    Palomba
  10. Moskowitz
    Moskowitz

Groups

  1. Center for Hematologic Malignancies (79)
  2. Department of Medicine (79)
  3. Hematologic Malignancies, Division of (79)
  4. Lymphoma (79)
  5. Molecular Imaging and Therapy Service (79)
  6. Radiology, Department of (79)
  7. Survivorship Research (50)
  8. Population Sciences Research Program (45)
  9. Executive Committee, Center for Hematologic Malignancies (31)
  10. Radiation Oncology, Department of (31)
  1. "Center for Hematologic Malignancies"
  2. "Lymphoma"
  3. "Molecular Imaging and Therapy Service"
  4. "Andrew Zelenetz"
Formats
  1. Meeting Abstract (42)
  2. Journal Article (35)
  3. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (79)
  2. Department of Medicine (79)
  3. Hematologic Malignancies, Division of (79)
  4. Lymphoma (79)
  5. Molecular Imaging and Therapy Service (79)
  6. Radiology, Department of (79)

More Groups

People
  1. Andrew Zelenetz (79)
  2. Heiko Schoder (63)
  3. Paul Hamlin (49)
  4. Ariela Noy (46)
  5. David Straus (46)
  6. Matthew Matasar (45)

More People

Years
  1. 2024 (2)
  2. 2023 (9)
  3. 2022 (5)
  4. 2021 (8)
  5. 2020 (4)
  6. 2019 (5)

More Years

Publications
  1. Blood (33)
  2. Journal of Clinical Oncology (12)
  3. Hematological Oncology (7)
  4. Annals of Oncology (4)
  5. Journal of Nuclear Medicine (4)
  6. Haematologica (3)

More Publications

Publishers
  1. American Society of Hematology (34)
  2. American Society of Clinical Oncology (12)
  3. Wiley Blackwell (8)
  4. Oxford University Press (4)
  5. Society of Nuclear Medicine (4)
  6. Ferrata Storti Foundation (3)

More Publishers

Results (79)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Prognostic value of (18)F-FDG PET/CT in diffuse large B-cell lymphoma treated with a risk-adapted immunochemotherapy regimen
    Journal Article

    Michaud, L.; Bantilan, K.; Mauguen, A.; Moskowitz, C. H.; Zelenetz, A. D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save